Christine Endicott

Title: Christine Endicott: Innovator in Antibody Purification Technology

Introduction

Christine Endicott is a prominent inventor based in Glastonbury, CT (US). She has made significant contributions to the field of biotechnology, particularly in the purification of bispecific antibodies. Her innovative work has implications for therapeutic applications and the advancement of antibody engineering.

Latest Patents

Christine holds a patent for a "Purification platform for bispecific antibodies." This patent describes a high-resolution protein A chromatography method that employs a chaotropic agent and pH gradient or pH step elution buffer. This technique results in improved peak resolution between closely related molecular species. The method allows for the effective separation of bispecific antibodies containing a protein A-binding-ablating substitution CH3 domain paired with a protein A-binding CH3 domain from monospecific antibodies. Useful chaotropic agents mentioned in her patent include magnesium chloride and calcium chloride. Christine has 1 patent to her name.

Career Highlights

Christine is currently employed at Regeneron Pharmaceuticals, Inc., where she continues to work on innovative solutions in the field of biotechnology. Her expertise in antibody purification has positioned her as a valuable asset to her team and the company.

Collaborations

Christine has collaborated with notable colleagues, including Andrew Tustian and Benjamin Adams. These partnerships have fostered a collaborative environment that enhances the development of cutting-edge technologies in the industry.

Conclusion

Christine Endicott's contributions to antibody purification technology exemplify her dedication to innovation in biotechnology. Her work not only advances scientific understanding but also has the potential to improve therapeutic outcomes in medicine.